Article Text

Download PDFPDF
Valacyclovir-associated acute kidney injury

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Editor's note The authors used United States Adopted Names (acyclovir and valacyclovir) rather than International Nonproprietary Names (aciclovir and valaciclovir).

  • Contributors This report was created by JK, in conjunction with PS. The authors were both involved in the care of the patient. JK created the manuscript with supervision and oversight provided by PS.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • First published: Kirkland J, Suganthan P. Valacyclovir-associated acute kidney injury. BMJ Case Reports 2022;15:e249552.